Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Not applicableStudy completedNCT01178918What this trial is testingNon-specific Response to H1N1 VaccineWho this might be right forInfluenza H1N1 The University Clinic of Pulmonary and Allergic Diseases Golnik 14
Early research (Phase 1)Study completedNCT00724997What this trial is testingRandomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy VolunteersWho this might be right forSeasonal Human Influenza AVIR Green Hills Biotechnology AG 48
Early research (Phase 1)Study completedNCT00973895What this trial is testingVRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years OldWho this might be right forInfluenza A Virus, H1N1 SubtypeNovel Swine-Origin National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00952419What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 474
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Not applicableStudy completedNCT00965354What this trial is testingMechanisms of Severe Acute Influenza Consortium (MOSAIC)Who this might be right forInfluenza Imperial College London 131
Not applicableUnknownNCT01256931What this trial is testingAntibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.Who this might be right forOrgan Transplantation Sahlgrenska University Hospital 110
Early research (Phase 1)Study completedNCT04146623What this trial is testingSafety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal SprayWho this might be right forInfluenza Codagenix, Inc 33
Post-approval studies (Phase 4)UnknownNCT00936013What this trial is testingChinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled StudyWho this might be right forInfluenza Capital Medical University 400
Testing effectiveness (Phase 2)UnknownNCT01055990What this trial is testingBasic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsWho this might be right forVirus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more Shanghai Public Health Clinical Center 7
Not applicableStudy completedNCT01289418What this trial is testingSurveillance for Adverse Events Following Pandemic H1N1 ImmunizationWho this might be right forNovel Influenza A/H1N1 PHAC/CIHR Influenza Research Network 6,525
Not applicableUnknownNCT00845403What this trial is testingAntigen-specific Immune Response to Hepatitis B Virus in UteroWho this might be right forHepatitis B National University Hospital, Singapore 60
Post-approval studies (Phase 4)Study completedNCT01499914What this trial is testingCohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza VaccinationWho this might be right forCystic Fibrosis With Gastrointestinal Manifestation Assistance Publique - Hôpitaux de Paris 439
Testing effectiveness (Phase 2)Study completedNCT01369862What this trial is testingStudy of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy AdultsWho this might be right forInfluenza, Human AVIR Green Hills Biotechnology AG 80
Not applicableStudy completedNCT03743688What this trial is testingKinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy AdultsWho this might be right forInfluenzaInfluenza, HumanVaccine Reaction+4 more Vanderbilt University Medical Center 10
Large-scale testing (Phase 3)Study completedNCT01031719What this trial is testingClinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsWho this might be right forH1N1 Influenza VirusInvasive Solid Tumors Chiltern Pesquisa Clinica Ltda 59
Testing effectiveness (Phase 2)Study completedNCT01078701What this trial is testingDose Finding Study of Single Dose GHB11L1 in Healthy AdultsWho this might be right forInfluenza, Human AVIR Green Hills Biotechnology AG 49
Large-scale testing (Phase 3)Study completedNCT01032395What this trial is testingImmunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes MellitusWho this might be right forH1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more Chiltern Pesquisa Clinica Ltda 342
Large-scale testing (Phase 3)Study completedNCT06385821What this trial is testingProve Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol PlusWho this might be right forInfluenzaInfluenza AInfluenza, Human+8 more NPO Petrovax 824